Provision of Technical Assistance for Implementation of Comprehensive HIV Care, Treatment, and Support Programs in the United Republic of Tanzania through CDC under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH16 164802CONT17

Opportunity Information: Apply for CDC RFA GH16 164802CONT17

This funding opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health, focused on Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR). The core purpose is to provide technical assistance to support the implementation and strengthening of comprehensive HIV care, treatment, and support programs in the United Republic of Tanzania. In practical terms, the award is meant to help sustain and improve program delivery rather than to launch an entirely new standalone project, and it is positioned within the broader U.S. government HIV response framework led by PEPFAR.

The opportunity is identified as CDC RFA GH16-164802CONT17, and it is categorized explicitly as "Continuation" funding. Continuation opportunities are generally structured to extend or supplement ongoing work that has already been funded, often with expectations that recipients will build on established systems, partnerships, and demonstrated performance. The funding instrument is a cooperative agreement, which usually indicates substantial involvement by CDC in the program. Unlike a standard grant where the recipient typically has more autonomy, a cooperative agreement often involves CDC collaboration on technical direction, monitoring, and alignment with country and PEPFAR strategies, including support for data use, quality improvement, and adherence to U.S. government and host-country requirements.

The activity category is Health, and the CFDA number listed is 93.067, a CDC global health assistance catalog listing commonly associated with international HIV-related programming. The description emphasizes "comprehensive HIV care, treatment, and support," which typically encompasses a broad service continuum: antiretroviral therapy (ART) service delivery and optimization, linkage to and retention in care, adherence support, viral load monitoring and suppression efforts, management of advanced HIV disease, opportunistic infection prevention and treatment (including TB/HIV coordination where applicable), and patient-centered support services that help people living with HIV stay engaged in care. Because the award is framed as technical assistance, the expected work often includes strengthening clinical and program systems, building local capacity, improving service quality, and ensuring that national guidelines and PEPFAR priorities are implemented consistently across supported sites and partners.

The listing indicates an expected 10 awards, suggesting multiple recipients or implementing partners could be funded to provide complementary technical assistance across regions, populations, or service delivery platforms. The award ceiling is shown as 0, which commonly reflects that a specific maximum dollar amount is not being stated in the synopsis and that funding levels may be determined through continuation budgets, negotiations, availability of funds, and performance considerations rather than a single advertised cap. The opportunity was created on February 2, 2017, with an original closing date of March 31, 2017, which signals a defined application window for eligible entities to compete or be considered for continuation support under the stated announcement.

Eligibility is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," meaning the synopsis is signaling that the eligible applicant pool is not fully specified in the short summary. In many CDC/PEPFAR continuation cooperative agreements, eligibility may be limited to existing recipients or a defined set of organizations with a prior award, demonstrated capacity, or a specific relationship to the ongoing program. Without the additional eligibility text, the safest interpretation is that applicants needed to confirm eligibility in the full announcement package before applying, because continuation opportunities frequently narrow eligibility to ensure program continuity and alignment with existing investments.

Overall, the opportunity is best understood as CDC-supported, PEPFAR-funded technical assistance to strengthen Tanzania's HIV treatment and care ecosystem through cooperative partnership, with multiple expected awards, a continuation posture aimed at sustaining and improving ongoing program results, and an emphasis on comprehensive clinical care and supportive services that improve outcomes for people living with HIV.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Provision of Technical Assistance for Implementation of Comprehensive HIV Care, Treatment, and Support Programs in the United Republic of Tanzania through CDC under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 02, 2017.
• Applicants must submit their applications by Mar 31, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH16 164802CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: